Thomas Eade
Overview
Explore the profile of Thomas Eade including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schuler T, Hruby G, Wong S, Roderick S, Eade T
Int J Radiat Oncol Biol Phys
. 2025 Feb;
121(3):844-845.
PMID: 39909613
No abstract available.
2.
Challis B, Kneebone A, Eade T, Guo L, Atyeo J, Brown C, et al.
Clin Transl Radiat Oncol
. 2024 Dec;
50:100896.
PMID: 39676999
Background: Nodal only recurrence post radical prostatectomy (RP) is increasingly recognised in the PSMA scan era. Management is controversial with a curative approach usually incorporating prostate bed and nodal irradiation...
3.
Sengupta C, Nguyen D, Li Y, Hewson E, Ball H, OBrien R, et al.
Med Phys
. 2024 Nov;
52(3):1941-1949.
PMID: 39579383
Purpose: The US National Institutes of Health state that Sharing of clinical trial data has great potential to accelerate scientific progress and ultimately improve public health by generating better evidence...
4.
Schuler T, Roderick S, Wong S, Kejda A, Grimberg K, Lowe T, et al.
Int J Radiat Oncol Biol Phys
. 2024 Oct;
121(3):585-595.
PMID: 39353478
Purpose: The feasibility of simulation-free radiation therapy (SFRT) has been demonstrated but information regarding its routine care impact and scalability is lacking. Methods And Materials: In this single-institution, retrospective cohort...
5.
Lawless A, Kumar S, Bindra J, Sywak M, Chou A, Turchini J, et al.
Asia Pac J Clin Oncol
. 2024 Aug;
20(6):681-689.
PMID: 39145924
Anaplastic thyroid cancer (ATC), a rare and highly aggressive malignancy, is characterized by an exceptionally poor prognosis, where the majority of patients present with extensive local invasion and/or distant metastases....
6.
Leow B, Eade T, Hruby G, Lieng H, Hsiao E, Brown C, et al.
J Med Imaging Radiat Oncol
. 2024 Apr;
68(6):721-728.
PMID: 38618900
Introduction: In the current American Joint Committee on Cancer staging system, patients with pelvic nodal metastases are considered stage IV prostate cancer. This study aims to investigate whether men with...
7.
Loh C, Chui J, Zhuo K, Canagasingham A, Guminski A, Delprado W, et al.
Urol Case Rep
. 2024 Feb;
53:102676.
PMID: 38420334
Microcystic adenocarcinoma is an uncommon histologic variant of prostate carcinoma. Despite its rarity, it has gained increasing recognition over the past decade for its diagnostic challenges and unclear prognostic significance....
8.
Kejda A, Bromley R, Bell L, Stewart M, Kneebone A, Eade T, et al.
Phys Med
. 2023 Sep;
114:103155.
PMID: 37776699
Purpose: Physical separation of healthy tissue and target volumes in prostate radiotherapy through the insertion of hydrogel can improve patient toxicity rates. An iodised hydrogel may provide anatomical separation of...
9.
Kejda A, Quinn A, Wong S, Lowe T, Fent I, Gargett M, et al.
Phys Imaging Radiat Oncol
. 2023 Sep;
28:100490.
PMID: 37705690
Background And Purpose: Simulation-free radiotherapy, where diagnostic imaging is used for treatment planning, improves accessibility of radiotherapy for eligible palliative patients. Combining this pathway with online adaptive radiotherapy (oART) may...
10.
Siva S, Sakyanun P, Mai T, Wong W, Lim A, Ludbrook J, et al.
J Clin Oncol
. 2023 May;
41(19):3493-3498.
PMID: 37179526
JCO In a randomized phase II clinical trial, the Trans Tasman Radiation Oncology Group compared single- versus multifraction stereotactic ablative body radiotherapy (SABR) in 90 patients with 133 oligometastases to...